Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine Treatment in Children With Dystonic Cerebral Palsy
NCT01361373Phase 4Unknown
- Sponsor
- Shaare Zedek Medical Center
- Start
- May 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levodopa in cerebral palsy (CP) (2 arms), sponsored by Shaare Zedek Medical Center. Primary endpoints: Quality of Upper Extremity Skills Test at 2 years and Goal Attainment Scale at 2 weeks. Status: unknown.
02
Drugs
levodopa
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT01361373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01361373.